LLY

922.39

-1.51%↓

JNJ

186.29

-0.03%↓

UNH

324.11

+0.82%↑

NVS

126.28

-0.09%↓

ABT

126.19

+1.02%↑

LLY

922.39

-1.51%↓

JNJ

186.29

-0.03%↓

UNH

324.11

+0.82%↑

NVS

126.28

-0.09%↓

ABT

126.19

+1.02%↑

LLY

922.39

-1.51%↓

JNJ

186.29

-0.03%↓

UNH

324.11

+0.82%↑

NVS

126.28

-0.09%↓

ABT

126.19

+1.02%↑

LLY

922.39

-1.51%↓

JNJ

186.29

-0.03%↓

UNH

324.11

+0.82%↑

NVS

126.28

-0.09%↓

ABT

126.19

+1.02%↑

LLY

922.39

-1.51%↓

JNJ

186.29

-0.03%↓

UNH

324.11

+0.82%↑

NVS

126.28

-0.09%↓

ABT

126.19

+1.02%↑

Home・Akcijų sąrašas・Microbot Medical Inc

Microbot Medical Inc

Uždarymo kaina

2.03

Pirkti Parduoti

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

1.94

Max

2.06

Pagrindiniai rodikliai
By Trading Economics
Pajamos	-899K -3.5M
Pelno marža	-4,038.095
Darbuotojai	20
EBITDA	-84K -3.5M

Rekomendacijos
By TipRanks
Rekomendacijos	Pirkti
12 mėnesių prognozė	+491.13% upside

Dividendai
By Dow Jones
Kitas uždarbis	2025-11-12

Rinkos statistika
By TradingEconomics
Rinkos kapitalizacija	14M 142M
Ankstesnė atidarymo kaina	2.03
Ankstesnė uždarymo kaina	2.03

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Neutral Evidence

2.52 / 2.57 Palaikymas ir pasipriešinimas

Microbot Medical Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2025-11-07 21:06; UTC

Pagrindinės rinkos jėgos

JBS Down After Trump Calls for Probe into Meat-Packing Companies

2025-11-07 22:36; UTC

Uždarbis

McDonald's Stock Challenged By a Tougher Economy, Analyst Says. Plus, Marriott, Snowflake, and More. -- Barrons.com

2025-11-07 22:22; UTC

Uždarbis

The Score: GM, Tesla, Palantir, American Airlines and More Stocks That Defined the Week -- WSJ

2025-11-07 22:03; UTC

Uždarbis

Constellation Software 3Q Rev $2.95B >CSU.T

2025-11-07 22:03; UTC

Uždarbis

Constellation Software 3Q Net $210M >CSU.T

2025-11-07 22:03; UTC

Uždarbis

Constellation Software 3Q EPS $9.89 >CSU.T

2025-11-07 21:50; UTC

Rinkos pokalbiai

Financial Services Roundup: Market Talk

2025-11-07 21:50; UTC

Rinkos pokalbiai

Health Care Roundup: Market Talk

2025-11-07 20:59; UTC

Uždarbis

Palantir's CEO Says His Earnings Were the Best Ever. They Weren't Even the Best of the Week. -- Barrons.com

2025-11-07 20:26; UTC

Rinkos pokalbiai

Natural U.S. Gas Futures Extend Rally to Three Weeks -- Market Talk

2025-11-07 20:22; UTC

Uždarbis

Free-Spending Big Tech Dominates Earnings. As for the Rest: Don't Miss. -- Barrons.com

2025-11-07 20:04; UTC

Rinkos pokalbiai

Oil Futures Close Choppy Week With Losses -- Market Talk

2025-11-07 19:34; UTC

Rinkos pokalbiai

Gold Posts Small Gain for Week -- Market Talk

2025-11-07 19:31; UTC

Rinkos pokalbiai

Įsigijimai, susijungimai, perėmimai

Prices of Gas-Fired Power Plants Have Room to Grow -- Market Talk

2025-11-07 19:17; UTC

Uždarbis

These Stocks Are Moving the Most Today: Tesla, Expedia, Take-Two, Block, Affirm, Sunrun, Globus Medical, JFrog, and More -- Barrons.com

2025-11-07 19:09; UTC

Uždarbis

Wendy's Turnaround Won't Be Easy. Earnings, and the Stock, Tell the Story. -- Barrons.com

2025-11-07 19:08; UTC

Uždarbis

KKR Defied Private-Equity Fundraising Slump in the Third Quarter -- WSJ

2025-11-07 18:31; UTC

Rinkos pokalbiai

U.S. Oil RIg Count Unchanged at 414 -- Market Talk

2025-11-07 17:27; UTC

Rinkos pokalbiai

EPA Announces New Exemptions to Biofuel Blending Rules -- Market Talk

2025-11-07 17:20; UTC

Rinkos pokalbiai

Eli Lilly GLP-1 Deal with Trump Administration Provides Net Boost -- Market Talk

2025-11-07 17:20; UTC

Rinkos pokalbiai

Tech, Media & Telecom Roundup: Market Talk

2025-11-07 17:20; UTC

Rinkos pokalbiai

Financial Services Roundup: Market Talk

2025-11-07 17:20; UTC

Rinkos pokalbiai

Health Care Roundup: Market Talk

2025-11-07 17:17; UTC

Įsigijimai, susijungimai, perėmimai

Satair Expects to Complete Purchase in Early 2026

2025-11-07 17:17; UTC

Įsigijimai, susijungimai, perėmimai

Satair: Deal Includes Unical's and ecube's Seven Operational Sites and Offices, With Combined 2024 Rev of $298M and Headcount of 413

2025-11-07 17:15; UTC

Įsigijimai, susijungimai, perėmimai

Airbus Unit Satair to Buy Unical Aviation From Platinum Equity

2025-11-07 17:09; UTC

Rinkos pokalbiai

PENN Is Falling Further Behind Competitors -- Market Talk

2025-11-07 16:49; UTC

Rinkos pokalbiai

Losing ESPN Partnership Will Hurt PENN -- Market Talk

2025-11-07 16:24; UTC

Rinkos pokalbiai

OPEC+'s Output Hike Pause Comes Amid Excess Supply, Lower Spare Capacity -- Market Talk

2025-11-07 16:17; UTC

Rinkos pokalbiai

Oil Market Faces Oversupply But "Glut" Might Be Overblown -- Market Talk

Akcijų palyginimas

Kainos pokytis

Microbot Medical Inc Prognozė

Kainos tikslas

By TipRanks

491.13% į viršų

12 mėnesių prognozė

Vidutinis 12 USD 491.13%

Aukščiausias 12 USD

Žemiausias 12 USD

Remiantis 1 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Microbot Medical Inc kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Pirkti

1 ratings

Pirkti

Laikyti

Parduoti

Remiantis 1 analitikų, pateikusių Microbot Medical Inc akcijų reitingus – Dist per pastaruosius 3 mėnesius.

Techninis įvertinimas

By Trading Central

2.52 / 2.57Palaikymas ir pasipriešinimas

The bullish and bearish events are balanced.

Recent bullish events outweigh bearish events.

All events are bullish.

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

Apie bendrovę Microbot Medical Inc

Microbot Medical Inc., a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system which allows physicians to conduct a catheter-based procedure from outside the catheterization laboratory, and avoid radiation exposure, physical strain, and the risk of cross contamination for use in cardiovascular, peripheral, and neurovascular spaces. It also provides NovaCross, an intellectual property and technology in the field of intraluminal revascularization devices with anchoring mechanism and integrated microcatheter. The company has a strategic collaboration agreement with Stryker Corporation for technology co-development; and Phase 2 collaboration agreement with Corewell Health for the development of LIBERTY endovascular robotic system. Microbot Medical Inc. was founded in 2010 and is based in Braintree, Massachusetts.